Loading...
Immune checkpoint inhibitors in small cell lung cancer
Small cell lung cancer (SCLC) is a rapidly progressive cancer that often debilitates patients within months of detection and quickly becomes refractory to the limited options of therapy. While SCLC is not generally considered an immunogenic tumor, clinical experience suggests that patients with robu...
Saved in:
| Published in: | J Thorac Dis |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
AME Publishing Company
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5861263/ https://ncbi.nlm.nih.gov/pubmed/29593891 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2017.12.51 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|